In Korea, doctors actively use biomarkers such as next-generation sequencing (NGS) for disease diagnosis, but an expert said they have limited options to prescribe related treatments.Kang Jin-hyoung, a professor of oncology at Seoul St. Mary’s Hospital, said this and other remarks in a seminar on pr
Prestige Biopharma said that Dr. Reddy's Laboratories would market Tuznue, its Herceptin biosimilar, in South America and Southeast Asia.Under the accord, Prestige Biopharma will entrust Dr. Reddy's Laboratories with exclusive commercialization rights for Tuznue in eight countries -- five in South A
Samsung Bioepis said Thursday that SB3, a biosimilar of Herceptin (ingredient: trastuzumab), showed similar long-term survival results to its original drug after a median follow-up of 68 months from the phase 3 study.The five-year results are the longest monitored data as of December 2021 for a tras
SAN ANTONIO, Texas -- By Kim Yun-mi/Korea Biomedical correspondent - Novartis said its CDK4.6 inhibitor Kisqali (ingredient: ribociclib) improved overall survival (OS) across subtypes of metastatic hormone receptor-positive breast cancer, according to results of phase 3 MONALEESA studies presented a
Seoul National University Hospital (SNUH) said that the regulatory authorities have approved the hospital's clinical research plan for CAR-T treatment targeting acute lymphoblastic leukemia in children and adolescents.The approval comes eight months after the hospital submitted such clinical researc
Deep Bio said that its deep learning-based prostate cancer pathology diagnosis technology using a Gleason grading system acquired NET (new excellent technology) certification on Tuesday.NET certification is a certification system implemented by the Ministry of Trade, Industry and Energy to promote c
Major multinational pharmaceutical companies are expected to attend the annual J.P. Morgan Healthcare Conference in San Francisco, CA., in the U.S. in January, drawing attention to whether Korean biotech companies will join the event.As the upcoming conference will be held face to face, Korean compa
Korea's new Covid-19 cases surpassed 7,000 for the first time on Wednesday, despite the government’s suspension of the "living-with-covid" scheme to re-strengthen quarantine restrictions.On Wednesday, the Korea Disease Control and Prevention Agency (KDCA) confirmed 7,175 new virus cases, including 7
SAN ANTONIO, Texas -– By Kim Yun-mi/Korea Biomedical Review correspondent - HER2 protein tyrosine kinase inhibitor (TKI) Tukysa (ingredient: tucatinib) and next-generation antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) are at the center of attention of the San Antonio Breast Cancer S
Myongji Hospital said it has obtained a Level 1 rating, the highest rating in the medical quality evaluation conducted by the Ministry of Health and Welfare, for two years in a row.The hospital stressed that the feat is significant as it confirmed that it has maintained and provided high-quality med
NGeneBio said it plans to realize the era of personalized treatment by adding companion diagnosis, liquid biopsy, and AI technology to next-generation sequencing (NGS), which has revolutionized cancer and rare diseases diagnosis.NGS is the latest technology to mass-produce DNA sequence data and anal
CHICAGO, Ill. -- By Shim Hyun-tai/Korea Biomedical Review correspondent - The 2021 Radiological Society of North America (RSNA 2021) successfully finished its five day-run at the McCormick Place Convention Center last Thursday, with global companies, including Korean firms, demonstrating the latest
SAN ANTONIO, Texas -- By Kim Yun-mi/Korea Biomedical Review correspondent - Switching from an aromatase inhibitor to fulvestrant after detecting ESR1 (Estrogen Receptor 1) mutation could double progression-free survival (PFS) in patients with hormone receptor-positive breast cancer being treated wit
A research team at Samsung Medical Center (SMC) has developed a smartphone application that allows easy skin management by measuring skin moisture.The team, led by Professor Lee Jong-hee of the Department of Dermatology, stressed that the team’s skin moisture measurement method using bio-display is
EOFlow said it has agreed to export 45.3 billion won ($38.5 million) worth of its EOPatch, its wearable insulin pump, to PT. Prasasti Nusantara Sukses (PT. PNS), an Indonesian medical device company.PT. PNS will also hold exclusive sales rights for the device in Indonesia until Dec. 5, 2026.EOFlow s
The continued spread of the new Omicron variant has prompted Korean vaccine makers to review whether to develop Omicron-targeted Covid-19 vaccines.Industry sources said Eyegene, mCureX Therapeutics, and Eubiologics are mulling developing a new Omicron-specific vaccine or a polyvalent vaccine.On Wedn
Despite fierce backlash from parents and students, the government said Tuesday that it would push ahead with reinforcing the vaccine mandate for students aged 12-18 from February.The new measure comes as the vaccination rate for those aged 12-17 stood at 32.5 percent, far lower than the average. Und
ASP Korea is promoting its infection control system in line with the growing awareness of infection amid the Covid-19 pandemic.The company held a press conference in Seoul on Monday to emphasize the importance of hospital infection control and introduce its sterilization system.ASP is an infection c
After the government put on hold measures to “live with Covid” amid rising Covid-19 cases, presidential candidates criticized the government for hastily attempting to return to normalcy without proper preparations.One candidate demanded expanding public healthcare services, and another, revising the
Korea operates a national health insurance program. All Korean nationals are obligated to subscribe to it and pay insurance premiums set by the government.Under this system, insured people pay premiums differentially according to their incomes and assets, and the nation provides them with equal medi